Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| GILD | Gilead Sciences, Inc. | -0.62% | 76.50 | 1.0% | $1914.95m | |
| AMGN | Amgen, Inc. | 5.60% | 208.88 | 1.3% | $915.32m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.42% | 498.75 | 2.6% | $847.19m | |
| BIIB | Biogen, Inc. | 3.82% | 304.47 | 1.5% | $744.46m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 7.40% | 242.16 | 1.9% | $592.84m | |
| MRNA | Moderna, Inc. | -3.01% | 32.20 | 0.0% | $535.82m | |
| ILMN | Illumina, Inc. | 6.45% | 272.99 | 3.5% | $473.01m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.47% | 90.35 | 2.0% | $283.66m | |
| A | Agilent Technologies, Inc. | 4.95% | 72.33 | 1.6% | $222.85m | |
| INCY | Incyte Corp. | 3.90% | 77.07 | 2.5% | $183.14m | |
| EXAS | EXACT Sciences Corp. | 3.08% | 57.60 | 21.0% | $182.24m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 2.96% | 86.06 | 4.3% | $164.43m | |
| SGEN | Seattle Genetics, Inc. | 6.68% | 118.67 | 6.1% | $161.87m | |
| NVAX | Novavax, Inc. | -1.21% | 13.86 | 114.7% | $117.94m | |
| SRPT | Sarepta Therapeutics, Inc. | 3.20% | 95.98 | 14.0% | $98.31m |
Company Profile
Catalyst Biosciences, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel medicines to address serious medical conditions. The company was founded on August 20, 2015 and is headquartered in South San Francisco, CA.